A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.

Solvay

Status and phase: Completed; Phase 2

Conditions: Obesity

Treatments: Drug: Metformin and Metformin + Fenofibrate

Study type: Interventional

Funder types: Industry

Identifiers

NCT00349635

2004-001731-28

C LF23-0121 04 01

Details and patient eligibility

About

To investigate the effect on body weight of a combination fenofibrate and metformin on top of a moderate balanced calorie-deficit diet.

Sex: All

Ages: 30 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Both genders, BMI ≥ 30 kg/m² and <40 kg/m².

Exclusion criteria

• Known abnormal thyroid hormone levels, or high thyroid stimulating hormone (TSH) level.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind